Renalase Gene Polymorphisms in Patients With Type 2 Diabetes, Hypertension and Stroke

Adeyemo, A., Gerry, N., Chen, G., Herbert, A., Doumatey, A., Huang, H., et al. (2009). A genome-wide association study of hypertension and blood pressure in African Americans. Public Library of Science Genetics, 5, e1000564.

Aronow, W. S. (2008). Hypertension and the older diabetic. Clinics in Geriatric Medicine, 24, 489–501.

Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., et al. (2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics, 41, 703–707.

Cowley, A. W., Jr. (2006). The genetic dissection of essential hypertension. Nature Reviews Genetics, 7, 829–840.

Derosa, G., Salvadeo, S., & Cicero, A. F. (2006). Recommendations for the treatment of hypertension in patients with DM: Critical evaluation based on clinical trials. Current Clinical Pharmacology, 1, 21–33.

Desir, G. V. (2007). Renalase is a novel renal hormone that regulates cardiovascular function. Journal of the American Society of Hypertension, 1, 99–103.

Desir, G. V. (2008). Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Current Opinion in Nephrology and Hypertension, 17, 181–185.

Desir, G. V. (2011). Role of renalase in the regulation of blood pressure and the renal dopamine system. Current Opinion in Nephrology and Hypertension, 20, 31–36.

Gu, R., Lu, W., Xie, J., Bai, J., & Xu, B. (2011). Renalase deficiency in heart failure model of rats–a potential mechanism underlying circulating norepinephrine accumulation. Public Library of Science, 6, e14633.

Kannel, V. B. (2000). Elevated systolic blood pressure as a cardiovascular risk factor. American Journal of Cardiology, 85, 251–255.

Li, G., Xu, J., Wang, P., Velazquez, H., Li, Y., Wu, Y., et al. (2008). Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation, 117, 1277–1282.

Madisen, L., Hoar, D. I., Holroyd, C. D., Crisp, M., & Hodes, M. E. (1987). The banking : The effects of storage of blood and isolated DNA on the integrity of DNA. American Journal of Medical Genetics, 27, 379–390.

Matarin, M., Singleton, A., Hardy, J., & Meschia, J. (2010). The genetics of ischaemic stroke. Journal of Internal Medicine, 267, 139–155.

Mazzone, T. (2007). Prevention of macrovascular disease in patients with diabetes mellitus: Opportunities for intervention. American Journal of Medicine, 120, S26–S32.

Puddu, P., Puddu, G. M., Cravero, E., Ferrari, E., & Muscari, A. (2007). The genetic basis of essential hypertension. Acta Cardiologica, 62, 281–293.

Rampersaud, E., Damcott, C. M., Fu, M., Shen, H., McArdle, P., et al. (2007). Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the old order Amish. Diabetes, 56, 3053–3062.

Reddy, M. V., Wang, H., Liu, S., Bode, B., Reed, J. C., et al. (2011). Association between type 1 diabetes and GWAS SNPs in the southwest US Caucasian population. Genes & Immunity, 12, 208–212.

Rohr, J., Kittner, S., Feeser, B., Hebel, J. R., Whyte, M. G., Weinstein, A., et al. (1996). Traditional risk factors and ischemic stroke in young adults: The Baltimore-Washington Cooperative Young Stroke Study. Archives of Neurology, 53, 603–607.

Sharma, V., & McNeill, J. H. (2006). The etiology of hypertension in the metabolic syndrome part two: The gene environment interaction. Current Vascular Pharmacology, 4, 305–320.

Sowers, J. R. (2004). Insulin resistance and hypertension. American Journal of Physiology. Heart and Circulatory Physiology., 286, H1597–H1602.

Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001). Diabetes, hypertension and cardiovascular disease. An update. Hypertension, 37, 1053–1059.

Wong, W. T., Wong, S. L., Tian, X. Y., & Huang, Y. (2010). Endothelial dysfunction: The common consequence in diabetes and hypertension. Cardiovascular Pharmacology, 55, 300–307.

World Health Organization. International Society of Hypertension Guideline for Management of Hypertension. (1999). Journal of Hypertension, 17, 151–183.

Wu, Y., Xu, J., Velazquez, H., Wang, P., Li, G., Liu, D., et al. (2011). Renalase deficiency aggravates ischemic myocardial damage. Kidney International, 79, 853–860.

Xu, J., Li, G., Wang, P., Velazquez, H., Yao, X., Li, Y., et al. (2005). Renalase is a novel soluble monoamine oxidase that regulates cardiac function and blood pressure. Journal of Clinical Investigation, 115, 1275–1280.

Zhao, Q., Fan, Z., He, J., Chen, S., Li, H., Zhang, P., et al. (2007). Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population. Journal of Molecular Medicine, 85, 877–885.